We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$255B
AUM Growth
-$3.63B
Cap. Flow
-$5.97B
Cap. Flow %
-2.34%
Top 10 Hldgs %
12.76%
Holding
4,482
New
462
Increased
1,845
Reduced
1,866
Closed
145

Top Buys

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$311M
2
EXR icon
Extra Space Storage
EXR
+$293M
3
KO icon
Coca-Cola
KO
+$246M
4
TCO
Taubman Centers Inc.
TCO
+$211M
5
NTAP icon
NetApp
NTAP
+$188M

Sector Composition

Rank Sector Weight
1 Technology 15.68%
2 Healthcare 14.19%
3 Financials 13.69%
4 Communication Services 8.77%
5 Real Estate 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVTA
4026
DELISTED
Invitae Corporation
NVTA
$5K ﹤0.01%
+359
New +$5.11K
ARAV
4027
DELISTED
Aravive, Inc. Common Stock
ARAV
$5K ﹤0.01%
+55
New +$5.57K
MTEM
4028
DELISTED
Molecular Templates, Inc.
MTEM
$5K ﹤0.01%
+8
New +$5.29K
KDNY
4029
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$5K ﹤0.01%
+30
New +$4.95K
BLCM
4030
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$5K ﹤0.01%
+24
New +$5.88K
CNCE
4031
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$5K ﹤0.01%
+355
New +$5.41K
OTIC
4032
DELISTED
Otonomy, Inc.
OTIC
$5K ﹤0.01%
+238
New +$6.67K
AGTC
4033
DELISTED
Applied Genetic Technologies Corporation
AGTC
$5K ﹤0.01%
+327
New +$6.27K
CCXI
4034
DELISTED
ChemoCentryx, Inc.
CCXI
$5K ﹤0.01%
625
-9,962
-94% -$79.1K
EPZM
4035
DELISTED
Epizyme, Inc
EPZM
$5K ﹤0.01%
+222
New +$4.27K
XENT
4036
DELISTED
Intersect ENT, Inc
XENT
$5K ﹤0.01%
+191
New +$5.01K
DRNA
4037
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$5K ﹤0.01%
368
-62,571
-99% -$1.15M
ADXS
4038
DELISTED
Advaxis Inc
ADXS
$5K ﹤0.01%
+18
New +$5.69K
XLRN
4039
DELISTED
Acceleron Pharma
XLRN
$5K ﹤0.01%
+170
New +$5.49K
FLXN
4040
DELISTED
Flexion Therapeutics, Inc.
FLXN
$5K ﹤0.01%
+250
New +$5.04K
FPRX
4041
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$5K ﹤0.01%
+217
New +$4.83K
IMMU
4042
DELISTED
Immunomedics Inc
IMMU
$5K ﹤0.01%
+1,242
New +$5.08K
PGNX
4043
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$5K ﹤0.01%
+710
New +$4.3K
FCSC
4044
DELISTED
Fibrocell Science Inc.
FCSC
$5K ﹤0.01%
+64
New +$4.31K
NAVB
4045
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$5K ﹤0.01%
+170
New +$4.94K
LOXO
4046
DELISTED
Loxo Oncology, Inc
LOXO
$5K ﹤0.01%
+279
New +$3.81K
CORI
4047
DELISTED
Corium International, Inc.
CORI
$5K ﹤0.01%
+399
New +$4.5K
ANTH
4048
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$5K ﹤0.01%
+73
New +$3.38K
NVIV
4049
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
0
CASC
4050
DELISTED
Cascadian Therapeutics, Inc.
CASC
$5K ﹤0.01%
+235
New +$3.72K

Similar funds

Invesco's Q2 2015 Portfolio in Review

As of Q2 2015, Invesco held 4,482 positions worth $255B, down 1.4% from $258B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Invesco's Q2 2015 filing shows 462 new, 1,845 increased, 1,866 reduced and 145 closed positions. Its largest new stake was Anthem, Inc.: 1,170,000 shares worth $61.6M. The largest sale was Fiat Chrysler Automobiles N.V., an estimated $3.11B.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • Invesco's largest Q2 2015 buy was Anthem, Inc.: 1,170,000 shares worth $61.6M.
  • Invesco added most to Equinix in Q2 2015, an estimated $311M increase.
  • Invesco's biggest Q2 2015 reduction was Fiat Chrysler Automobiles N.V., cutting an estimated $3.11B.
  • Invesco fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $126M.
  • Invesco's ten largest holdings make up 13% of its $255B portfolio in Q2 2015.
  • Invesco opened 462 new positions and closed 145 in Q2 2015.
  • Invesco's portfolio value fell 1.4% quarter-over-quarter to $255B.

Based on Invesco's 13F filing for Q2 2015, filed 14 Aug 2015.